Preview | Issue Date | Title | Author(s) | Access |
![Clinical and Pathological Characterization of Lynch-Like.pdf.jpg](/retrieve/4d855df9-813f-44a7-b1ef-9dda89e08678/Clinical%20and%20Pathological%20Characterization%20of%20Lynch-Like.pdf.jpg) | Feb-2020 | Clinical and Pathological Characterization of Lynch-Like Syndrome | Picó, Maria Dolores; Castillejo, Adela; Murcia, Oscar; Giner Calabuig, Mar; Alustiza, Miren; Sánchez, Ariadna; Moreira, Leticia; Pellise, Maria; Castells, Antoni; Carrillo-Palau, Marta; Ramon y Cajal, Teresa; Gisbert-Beamud, Alexandra; LLORT, GEMMA; Yagüe, Carmen; López-Fernández, Adriá; Alvarez-Urturi, Cristina; Cubiella, Joaquín; Rivas, Laura; Rodríguez-Alcalde, Daniel; Herraiz, Maite; Garau, Catalina; Dolz, Carlos; Bujanda, Luis; Cid, Lucía; Povés, Carmen; Garzon, Marta; Salces, Inmaculada; Ponce, Marta; Hernández-Villalba, Luís; Alenda, Cristina; Balaguer, Francesc; Soto, Jose-Luis; JOVER, RODRIGO | ![](/image/openAccess.png) |
![Differential presentation of hypersensitivity reactions to.pdf.jpg](/retrieve/065e6e67-d3a3-403e-94e1-bcddb73cae5e/Differential%20presentation%20of%20hypersensitivity%20reactions%20to.pdf.jpg) | 2023 | Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization | Jimenez-Rodriguez, Teodorikez-Wilfox; de las Vecillas, Leticia; Labella, Marina; Lynch, Donna-Marie ; Besz, Kylie Marie; Marquis, Kathleen; Burgos, Amparo; Soriano Gomis, Victor; Lozano , Inmaculada; Montoyo Antón, Rosana Ana; Marco de la Calle, Francisco; González Delgado, María Purificación; Gutiérrez, Aurora; Montenegro, Estefanía; Rodríguez, Fernando; Fernández Sánchez, Francisco Javier; Castells, Mariana | ![](/image/openAccess.png) |
![Omalizumab and other biologics in.pdf.jpg](/retrieve/ff78c4e7-a9c0-438e-83d7-96912e5d2e34/Omalizumab%20and%20other%20biologics%20in.pdf.jpg) | 2020 | Omalizumab and other biologics in drug desensitization | Fernández, Javier; Ruano-Zaragoza, María; Blanca-López, Natalia | ![](/image/closedAccess.png) |
![Modelo asistencial ambulatorio de alta resolución COVID-A2R una solución efectiva en el servicio.pdf.jpg](/retrieve/6ac45318-43fe-456a-87ee-745e0140ce62/Modelo%20asistencial%20ambulatorio%20de%20alta%20resoluci%c3%b3n%20COVID-A2R%20una%20soluci%c3%b3n%20efectiva%20en%20el%20servicio.pdf.jpg) | Apr-2022 | Modelo asistencial ambulatorio de alta resolución COVID-A2R: una solución efectiva en el servicio de urgencias para pacientes con COVID-19 y riesgo de evolución desfavorable | Moreno Pérez, Óscar; Ribes, Isabel; Fuertes Kenneally, Laura; Carratalá, José Manuel; Román, Francisco; Otero Rodríguez, Silvia; González de La Aleja, Pilar; Merino, Esperanza; Llorens Soriano, Pedro | ![](/image/openAccess.png) |
![Validation of a commercial allergen microarray platform for specific.pdf.jpg](/retrieve/b37bccc9-acd6-4ea7-b54b-b3a8bcbd10da/Validation%20of%20a%20commercial%20allergen%20microarray%20platform%20for%20specific.pdf.jpg) | Mar-2022 | Validation of a commercial allergen microarray platform for specific immunoglobulin E detection of respiratory and plant food allergens | Quan, Paola Leonor; Sabaté Brescó, Marina; DAMELIO, CARMEN MARIANA; Pascal, Mariona; García, Blanca Esther; Gastaminza, Gabriel; Blanca-López, Natalia; Alvarado, Maria Isabel; Fernández, Javier; Moya, Carmen; Bartra, Joan ; Ferrer, Marta; Goikoetxea, María José | ![](/image/closedAccess.png) |
![Lipid Transfer Protein Sensitization Risk of.pdf.jpg](/retrieve/faa0f2c3-c3ba-43a8-ad5c-7e8e7c56a813/Lipid%20Transfer%20Protein%20Sensitization%20Risk%20of.pdf.jpg) | Dec-2020 | Lipid Transfer Protein Sensitization: Risk of Anaphylaxis and Molecular Sensitization Profile
in Pru p 3-Sensitized Patients | Ruano-Zaragoza, Maria; Somoza, Maria Luisa; Jimenez-Rodriguez, Teodorikez; Soriano Gomis, Victor; González-Delgado, Purificación; Esteban-Rodriguez, Ángel; Palazón-Bru, Antonio; Miguel González, Blanca; Fernández-Sánchez, Javier | ![](/image/closedAccess.png) |
![When and How To Use Endoscopic Tattooing in the Colon An.pdf.jpg](/retrieve/0025cb91-8421-496b-abbb-5aab907a35bd/When%20and%20How%20To%20Use%20Endoscopic%20Tattooing%20in%20the%20Colon%20An.pdf.jpg) | May-2021 | When and How To Use Endoscopic Tattooing in the Colon: An International Delphi Agreement | Medina Prado, Lucía; hassan, cesare; Dekker, Evelien; Bisschops, Raf; Alfieri, Sergio; Bhandari, Pradeep; Bourke, Michael J.; Bravo, Raquel; Bustamante-Balen, Marco; Dominitz, Jason; Ferlitsch, Monika; Fockens, Paul; van der Veen, Monique; Lieberman, David; Herraiz, Maite; Kahi, Charles; Kaminski, Michal; Matsuda, Takahisa; Moss, Alan; Pellisé, María; Pohl, Heiko; Rees, Colin; Rex, Douglas K.; ROMERO SIMÓ, MANUEL; Rutter, Matthew D.; Sharma, Prateek; Shaukat, Aasma; Thomas-Gibson, Siwan; Valori, Roland; JOVER, RODRIGO | ![](/image/closedAccess.png) |
![Post-acute COVID-19 syndrome. Incidence and risk factors A Mediterranean cohort study.pdf.jpg](/retrieve/254d1d9e-2654-4a3e-9100-784cc021d452/Post-acute%20COVID-19%20syndrome.%20Incidence%20and%20risk%20factors%20A%20Mediterranean%20cohort%20study.pdf.jpg) | 2021 | Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study | Moreno-Pérez, Oscar; Merino, Esperanza; LEON-RAMIREZ, JOSE-MANUEL; Andres, Mariano; Ramos, Jose Manuel; Arenas-Jiménez, Juan; ASENSIO, SANTOS; Rosa, Sanchez; Ruiz-Torregrosa, Paloma; Galan, Irene; Scholz, Alexander; Amo, Antonio; González-delaAleja, Pilar; Boix, Vicente; Gil, Joan; On behalf of COVID19-ALC research group | ![](/image/openAccess.png) |
![Role of liver sinusoidal endothelial.pdf.jpg](/retrieve/c4f3b355-56d7-474d-9cae-bdd5f4d2afc4/Role%20of%20liver%20sinusoidal%20endothelial.pdf.jpg) | 2021 | Role of liver sinusoidal endothelial cells in liver diseases | Gracia-Sancho, Jordi; Caparrós, Esther; Fernández-Iglesias, Anabel; Francés, Rubén | ![](/image/closedAccess.png) |
![Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of.pdf.jpg](/retrieve/58b81418-66b3-4eeb-ac49-ef80935a3192/Experience%20with%20tocilizumab%20in%20severe%20COVID-19%20pneumonia%20after%2080%20days%20of.pdf.jpg) | 2020 | Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of
follow-up: A retrospective cohort study | Moreno-Pérez, Oscar; Andres, Mariano; LEON-RAMIREZ, JOSE-MANUEL; Sánchez-Payá, José; Rodríguez, Juan Carlos; Sánchez, Rosario; García Sevila, Raquel; Boix, Vicente; Gil, Joan; Merino, Esperanza | ![](/image/openAccess.png) |